about
Papanicolaou smears and cervical inflammatory cytokine responses.Impact of an educational intervention on women's knowledge and acceptability of human papillomavirus self-sampling: a randomized controlled trial in CameroonKnowledge and acceptability of pap smears, self-sampling and HPV vaccination among adult women in KenyaCalibration methods used in cancer simulation models and suggested reporting guidelinesImplementing a screening program for acromegaly in Latin America: necessity versus feasibilityAdherence to cervical cancer screening guidelines for U.S. women aged 25-64: data from the 2005 Health Information National Trends Survey (HINTS).Cancer screening in older adults.Application of the Carolina Framework for Cervical Cancer PreventionThe characteristics and relevant factors of Pap smear test use for women with intellectual disabilities in Taiwan.Design and preliminary analysis of a vaginal inserter for speculum-free cervical cancer screeningDysregulated expression of long noncoding RNAs in gynecologic cancers.Cost-effectiveness of a potential vaccine for human papillomavirus.Cervical cancer: screening hard-to-reach groups.Adoption of liquid-based cervical cancer screening tests by family physicians and gynecologistsFactors associated with obtaining health screening among women of reproductive ageCost effectiveness of a program to promote screening for cervical cancer in the Vietnamese-American populationPerceptions of cervical cancer and Pap smear screening behavior by women's sexual orientation.Utilization of papanicolaou smears by South Asian women living in the United States.Receipt of preventive services among privately insured minorities in managed care versus fee-for-service insurance plans.Increasing breast and cervical cancer screening in low-income womenAssessing the effectiveness of health interventions for cost-effectiveness analysis. Panel on Cost-Effectiveness in Health and MedicineFactors affecting compliance with clinical practice guidelines for pap smear screening among healthcare providers in africa: systematic review and meta-summary of 2045 individuals.Therapy of genital human papillomavirus infections. Part I: Indications for and justification of therapy.Economic evaluation of drug abuse treatment and HIV prevention programs in pregnant women: a systematic review.Increase in cervical cancer mortality in Spain, 1951-1991.Trends in cervical cancer in Fiji, 2000-2010Evaluation of Cervical Cancer Screening Programs in Côte d'Ivoire, Guyana, and Tanzania: Effect of HIV StatusExamining the cost-effectiveness of cancer screening promotion.Measurements of human papillomavirus transcripts by real time quantitative reverse transcription-polymerase chain reaction in samples collected for cervical cancer screening.Preventive Pap-smears: balancing costs, risks and benefitsCervical cancer screening in the United States and the Netherlands: a tale of two countriesPreventive medicine in the older patient: a United kingdom perspective.Economic evaluation of DNA ploidy analysis vs liquid-based cytology for cervical screening.Human papillomavirus anogenital disease in HIV-infected individuals.Developing clinical practice guidelines: types of evidence and outcomes; values and economics, synthesis, grading, and presentation and deriving recommendationsInequity of healthcare utilization on mammography examination and Pap smear screening in Thailand: Analysis of a population-based household surveyModelling the impact of population-based cytologic screening on cervical cancer incidence and mortality in Hong Kong: an age--period--cohort approach.Comparison of the Third Wave Invader human papillomavirus (HPV) assay and the digene HPV hybrid capture 2 assay for detection of high-risk HPV DNAInnovation in hospitals: a survey of the literature.Willingness to pay for cancer prevention.
P2860
Q21245656-AAA64149-27A4-4A4A-91D7-650911BD8B2DQ27338221-03311818-F63B-4C55-8F17-330C952DC054Q28727315-2DF07946-768A-47F7-BB88-CAF3CE9DD77AQ28749665-AE986DA1-2424-4513-8975-E9E48E58B7DCQ30251471-A4A31B59-AB1D-4C3A-89DD-F6F28FC9ADBEQ33516973-A35D1045-7167-4BF7-954F-6AEBFCF9E15BQ33560219-47DDD1B3-0253-44A5-A74F-30D66838646DQ33610692-3E1674D7-C9A4-4840-92F0-FE53AAEADDAFQ33722370-25570274-8590-4D42-9340-67BC770FCB64Q33745881-DD5AD073-424C-4C56-B3AF-78129BB44BBAQ33823613-24889E92-A444-427F-A275-412F916D96B8Q33865463-F7EAEEC1-BD64-4718-89CF-CA075B3F3B17Q34025260-1E137A89-CC75-4D2F-AB27-BF812A41D477Q34336621-E938B629-CF8A-4906-B6E7-9BC11BEA7813Q34452935-BE155014-2E40-4E23-B36A-71B021FDE2F4Q34508246-A1FA62B8-2019-419E-A418-AABE665D26BBQ34734089-8A3C7754-6942-4972-9B27-9B110AB5B50FQ34741485-D8503C87-4DC1-4623-BCA7-977002448689Q34743094-20EF85EC-44D3-44AD-8BDD-9E27962EDD5FQ34752028-77E619AA-BAF3-47C8-B7AA-5A6A236C549CQ34753553-E6C3429E-F969-4179-97BE-7C398CBD45F3Q34998502-AD135816-34DE-4F7D-A9D1-F4854888C89AQ35233958-2110DDB4-80BA-4E13-97A6-85B32CE8459EQ35551656-E98A071C-2B9D-469A-82A9-44658297CB7DQ35559035-C172F35C-4C58-4541-8BBF-7D3643A08A31Q35718995-64ED9B47-EE1C-4806-BA95-B2E13F831CB3Q35787542-EE99131D-76E8-44CF-ABED-D7E4A429A039Q35865876-B61E77AF-523B-4C52-85DC-FB97AE698E76Q35869420-13AF3E52-C690-4F79-9B92-17D082BB8294Q35994088-FED3FE2D-DBB9-4EE9-8B3E-F1BB89BC8A46Q36063746-3D6E2CB2-E57A-49EF-B6BA-F2CE61BFDD52Q36075322-98DEACA4-809C-4D68-AB91-80963FE01ADBQ36086827-7DB24F56-8FED-45B2-A6ED-2ECBBCFC159FQ36103164-2A6522D6-9357-42A4-825C-19548C1A1DB3Q36217828-08AC7AE5-AAAC-4F1F-9822-C6698A7EBF8DQ36304382-8B7CA815-FEF0-48A5-8810-07AB3D4534F0Q36615478-F3FC3336-C50E-4D7D-ADF2-080C8F76A0D8Q36672975-0005E5F2-228F-484B-9364-DE99B00BA9B2Q36691141-3C763C53-F981-4CAB-80E1-44AF9CCFBAB5Q37503094-256F55B1-D8C5-4471-AE71-1EF2A86D10A9
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 1990
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Screening for cervical cancer.
@en
type
label
Screening for cervical cancer.
@en
prefLabel
Screening for cervical cancer.
@en
P1476
Screening for cervical cancer.
@en
P2093
P304
P356
10.7326/0003-4819-113-3-214
P407
P577
1990-08-01T00:00:00Z